Harel Insurance Investments & Financial Services Ltd. acquired a new stake in Phreesia, Inc. (NYSE:PHR) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,736 shares of the company’s stock, valued at approximately $875,000.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Strs Ohio raised its holdings in shares of Phreesia by 290.3% in the first quarter. Strs Ohio now owns 12,100 shares of the company’s stock valued at $630,000 after acquiring an additional 9,000 shares in the last quarter. UBS Asset Management Americas Inc. raised its holdings in shares of Phreesia by 14.3% in the fourth quarter. UBS Asset Management Americas Inc. now owns 21,600 shares of the company’s stock valued at $1,172,000 after acquiring an additional 2,700 shares in the last quarter. Hsbc Holdings PLC raised its holdings in shares of Phreesia by 21.9% in the fourth quarter. Hsbc Holdings PLC now owns 19,493 shares of the company’s stock valued at $1,055,000 after acquiring an additional 3,503 shares in the last quarter. Principal Financial Group Inc. bought a new stake in shares of Phreesia in the fourth quarter valued at about $457,000. Finally, Truist Financial Corp raised its holdings in shares of Phreesia by 19.5% in the fourth quarter. Truist Financial Corp now owns 16,085 shares of the company’s stock valued at $873,000 after acquiring an additional 2,625 shares in the last quarter. Hedge funds and other institutional investors own 75.38% of the company’s stock.
In related news, CFO Thomas Altier sold 76,272 shares of the company’s stock in a transaction that occurred on Thursday, February 18th. The stock was sold at an average price of $71.96, for a total value of $5,488,533.12. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Edward L. Cahill sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, February 18th. The shares were sold at an average price of $72.00, for a total value of $720,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 151,888 shares of company stock worth $10,105,096. 28.20% of the stock is owned by insiders.
Shares of PHR stock opened at $50.62 on Tuesday. The stock’s 50-day simple moving average is $53.39 and its 200-day simple moving average is $54.50. The firm has a market capitalization of $2.27 billion, a price-to-earnings ratio of -84.37 and a beta of 1.42. Phreesia, Inc. has a fifty-two week low of $24.21 and a fifty-two week high of $81.59. The company has a debt-to-equity ratio of 0.09, a quick ratio of 7.24 and a current ratio of 7.24.
Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, March 31st. The company reported ($0.10) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.15) by $0.05. Phreesia had a negative return on equity of 16.07% and a negative net margin of 16.37%. As a group, equities analysts forecast that Phreesia, Inc. will post -0.67 earnings per share for the current year.
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.
Read More: What are high-yield dividend stocks?
Want to see what other hedge funds are holding PHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phreesia, Inc. (NYSE:PHR).
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.